Diagnosis and Treatment of - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

Diagnosis and Treatment of

Description:

Diagnosis and Treatment of Common Infectious Diseases Angela Heithaus, MD, PS Internal Medicine Seattle Healing Arts Center Gioconda 20 YO non-pregnant UW female ... – PowerPoint PPT presentation

Number of Views:183
Avg rating:3.0/5.0
Slides: 35
Provided by: seattlehea
Category:

less

Transcript and Presenter's Notes

Title: Diagnosis and Treatment of


1
Diagnosis and Treatment of Common Infectious
Diseases
Angela Heithaus, MD, PS Internal Medicine Seattle
Healing Arts Center
2
Gioconda
  • 20 YO non-pregnant UW female student sexually
    active 3 x week with 1 partner over past 6 months
    (he is asymptomatic), no prior medical history
    including STD
  • C/O pain on urination x 3 days with increased
    frequency and urgency, some suprapubic pain, no
    blood, back pain, vaginal d/c, fever

3
Epidemiology
  • First 10 years of life
  • Girls 3 Boys 1.1
  • Teen girls 0.5 episodes/year
  • Adult women 50-60 at least 1 episode/life time
  • Young, sexually active women 0.5 episodes/
    person year
  • Post-menopausal women 0.07 episodes per person
    per year

4
UTI
  • UNCOMPLICATED
  • Healthy, young, non-pregnant female
  • COMPLICATED
  • Everything else men, recurrent UTI, pyelo,
    in-dwelling catheters, pregnant, diabetic
  • Increased risk of failing therapy

5
Microbiology
  • 80-85 Escherichia coli
  • Staphylococcus saprophyticus, Proteus mirabilis,
    enterococci
  • Chlamydia-(acute urethral syndrome)
  • Negative standard culture

6
Diagnosis in Uncomplicated UTI
  • PEx
  • Nl temp
  • No costovertebral angle tenderness
  • Clinical Criteria
  • Dipstick leukocyte esterase (pyuria) and nitrite
    (Enterobacteriaceae)
  • 75-96 sensitivity 94-98 specificity for
    detecting gt10 leukocytes per HPF
  • Evaluation of mid stream urine (unspun) for
    pyuria is most valuable laboratory diagnostic
    test
  • (abnl 10 or more leukocytes per microL)

7
Selected Oral AB Regimens for Use in
Uncomplicated UTI
8
(No Transcript)
9
(No Transcript)
10
Giovanni Battista Morgagni
  • 22 YO M C/O (not homeless, recently
    incarcerated, IDU, in military, on athletic team
    or have family member with infection)
  • Local pain, swelling, redness
  • ? Drainage
  • ? Hit something a while ago
  • Denies fever, chills

11
Skin and Soft Tissue Infections
  • Cellulitis
  • Most common skin infection leading to
    hospitalization
  • Superficial, spreading infection involving
    subcutaneous tissue
  • Other Common Skin Infections
  • Impetigo, Folliculitis, Furuncles, and Carbuncles
  • Abscess

12
Impetigo, Folliculitis, Furuncle, Carbuncle
  • Impetigo superficial vesiculopustular skin
    infection occurring prominently on exposed areas
    of the face and extremities
  • FFC arise from hair follicle
  • Staph Aureus
  • Rarely require hospitalization
  • Respond to local measures
  • Recurrence may be prevented by decreasing staph
    aureus skin carriage

13
Abscess
  • Localized accumulation of polymorphonuclear
    leukocytes with tissue necrosis involving the
    dermis and subcutaneous tissue
  • Large numbers of microorganisms are typically
    present in the purulent material
  • Infection begins from tracking in from the skin
    surface

14
Microbiology
  • Most common microorgansim Staph Aureus
  • Increased incidence of community-associated
    infections due to methicillin-resistant S.
    Aureus (CA-MRSA)
  • Urban ER 61/119 MRSA isolated
  • An average of more than 3 organisms anaerobic in
    1/3 of cases (1/2 IDU)

15
Management
  • Incision, Drainage and culture
  • Fluctuant or has pointed
  • Culture ?MRSA
  • Bacteremia and Antibiotic Prophylaxis
  • AHA guidelines for those high risk for EC and who
    have hardware (oxacillin, cefazolin, vanco)
  • Oral Antibiotic Therapy
  • Not ready for ID, cellulitis, fever, high-risk
    features
  • Community Associated MRSA
  • Awareness of the local antimicrobial
    susceptibility patterns of community S. aureus
    isolates

16
Oral Antibiotic Therapy
Oral, peri-rectal, vulvovaginal abscesses
Amoxicillin-clavulanate 875/125 mg BID
Clindamycin 150 mg QID
PLUS Ciprofloxacin 500 mg BID

17
(No Transcript)
18
Galileo Galilei
  • 40 YO otherwise healthy, non-smoker C M presents
    C/O
  • dry cough x 2 weeks
  • clear sputum production and fatigue
  • Denies pharyngitis, fever, chills
  • Vitals Nl temp, RR, P

19
Acute Bronchitis
  • Over 90 are viral
  • Approximately 60 of patients seeking medical
    care are given antibiotics
  • One of the most common causes of antibiotic abuse
  • ACP and CDC state Pertussis is only form that
    should be treated

20
Usual Suspects
Coronavirus (types 1-3) Rhinovirus Influenza A
and B Parainfluenza Respiratory syncytial virus
Human metapneumovirus
21
Influenza
  • Cough, purulent sputum, fever, and constitutional
    complaints during the influenza season
  • Amantadine, rimantadine, or neuraminidase
    inhibitors
  • Must be given within 48 hours of symptom onset
    for demonstrable benefit

22
Other Suspects
  • Mycoplasma pneumoniae
  • Chlamydophila (formerly Chlamydia) pneumoniae
  • Bordetella pertussis (severe paroxysmal cough)

23
To Shoot or Not to Shoot
  • Pneumonitis vs Acute Bronchitis
  • Abnl vital signs
  • temp gt 38 C (100.4 F)
  • Pulse gt 100/min
  • RR gt24
  • Crackles on exam

24
Chronic CoughThink
  • Postnasal drip syndrome
  • Asthma
  • Gastroesophageal reflux

25
(No Transcript)
26
Beatrice
  • 28 YO otherwise healthy female who C/O
  • nasal congestion, purulent nasal discharge,
    maxillary tooth discomfort, hyposmia, and facial
    pain or pressure that is worse when bending
    forward, headache, fever (nonacute), halitosis,
    fatigue, cough, ear pain, and ear fullness

27
Acute Sinusitis
  • Almost all cases viral in etiology
  • Rhinovirus, parainfluenza, and influenza virus
  • Usually resolves in 7-10 days
  • 2 complicated by acute bacterial sinusitis
  • Streptococcus pneumoniae and Haemophilus
    influenzae
  • Self-limited, 75 resolve without tx in 1 month
  • Morbidity can include intracranial and orbital
    complications and of possibly developing chronic
    sinus disease

28
How many get it?
  • Average adult has from 2-3 colds and
    influenza-like illnesses per year
  • Average child six to 10
  • Represents approximately one billion acute
    respiratory illnesses annually
  • Approximately 0.5 to 2 percent of colds and
    influenza-like illnesses are complicated by acute
    bacterial sinusitis in adults
  • Annual incidence of acute community-acquired
    bacterial sinusitis is approximately 20 million
    cases

29
(No Transcript)
30
Comparison of Contemporary Guidelines for the
Diagnosis of Acute Community Acquired Bacterial
Sinusitis
  • CDC
  • Maxillary pain or tenderness in face or teeth
    rhinorrhea, no improvement x 7 days
  • Severe sxs
  • Plain films not needed
  • Sinus Allergy Health Partnership
  • Persistant sxs after 10 days or worsening after
    5-7 days
  • Nasal drainage, congestion, d/c facial
    pressure/pain hyposmia/anosmia fever cough
    ear sxs
  • Plain films, CT, MRI not needed

31
Treatment of Viral Rhinosinusitisin Adults
  • At first sign of a cold
  • Sustained release 1st generation antihistamine
    (chlorpheniramine, brompheniramine, clemastine),
    PLUS NSAID (ibuprofen, naproxen)
  • Continue taking both q 12 hrs until sxs clear
  • Add oral decongestant (pseudoephedrine) and/or a
    cough suppressant (dextromethrophan)
  • If sxs persist and are no better or worse after
    7-10 days, consider antibiotic therapy

32
Comparison Guidelines for the Treatment of ACA
Bacterial Sinusitis
  • CDC
  • Only those meeting clinical dx criteria
  • Narrow spectrum agents
  • Amoxicillin 1.5-3.5 g/d
  • Doxycycline 100mg BID
  • TMP-SMX 1DS BID
  • Sinus Allergy Health Partnership
  • Mild disease, - AB 4-6 wks
  • Amoxicillin
  • Amoxicillin-Clavulanate
  • Cefpodoxime
  • Cefuroxime axetil
  • Mild disease AB or moderate disease AB in 4-6
    wks
  • Any of above or
  • Levofloxacin or gatifloxicin
  • Moderate AB in 4-6 wks
  • Amoxicillin-Clavulanate or
  • Levofloxacin or gatifloxicin or
  • Combo tx with amoxicillin or clindamycin PLUS
    cefpodoxime or cefixime

33
Intranasal Steroids
  • Use is not recommended
  • OK in treating chronic sinus disease
  • Steroid therapy increases viral concentrations in
    nasal secretions in cases of viral rhinosinusitis

34
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com